Examkin

Question

Difficulty: MediumGynecologic Infections

A 27-year-old primigravida at 20 weeks gestation comes to the prenatal clinic complaining of severe vulvar itching and a burning sensation when urinating for the past four days. She also reports a noticeable increase in vaginal discharge but denies any foul odor, abdominal cramping, or vaginal bleeding. Her pregnancy has been uncomplicated to date. Vital signs are within normal limits. Pelvic examination reveals prominent erythema and excoriation of the vulva. The vaginal walls are erythematous, and there is a thick, white, clumpy discharge adherent to the vaginal mucosa. The cervical os is visually closed and appears normal. Vaginal pH is 4.2. Microscopic examination of the discharge mixed with a potassium hydroxide (KOH) preparation reveals branching, thread-like structures with budding organisms. Which of the following is the most appropriate next step in management for this patient?

  1. Intravaginal clotrimazole therapyAnswer
  2. B
    Single-dose oral fluconazole therapy
  3. C
    Reassurance as this represents normal leukorrhea of pregnancy
  4. D
    Oral metronidazole therapy
  5. E
    Intramuscular ceftriaxone therapy

Answer

Intravaginal clotrimazole therapy
This patient's presentation of severe vulvar pruritus, thick white clumpy discharge, normal vaginal pH (typically < 4.5), and microscopic evidence of branching pseudohyphae on a potassium hydroxide (KOH) preparation is highly diagnostic for vulvovaginal candidiasis (VVC). VVC is particularly common during pregnancy due to elevated estrogen levels causing increased vaginal glycogen stores, which promote fungal overgrowth. In pregnant patients, the treatment of choice for symptomatic VVC is a topical azole antifungal, such as intravaginal clotrimazole or miconazole, typically given for a 7-day course. Topical therapy is preferred because it effectively treats the local infection while bypassing the potential teratogenic risks associated with systemic azole absorption.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and microscopic findings.
The patient has intense vulvar pruritus, a thick clumpy vaginal discharge, a normal vaginal pH (4.2), and pseudohyphae on KOH prep.
This combination of findings is the classic diagnostic triad for acute vulvovaginal candidiasis (VVC).
2
Determine the optimal pharmacological intervention considering the patient's pregnancy status.
The patient is pregnant (20 weeks gestation). Systemic oral azole antifungals should be avoided due to documented teratogenic potential.
Treatment guidelines for VVC in pregnancy strictly recommend a 7-day course of topical vaginal azoles (such as clotrimazole or miconazole) to ensure effective microbial eradication while prioritizing fetal safety.

Key Concept

In pregnant patients, symptomatic vulvovaginal candidiasis should be treated with topical azole antifungals (e.g., intravaginal clotrimazole) rather than oral systemic therapies to avoid potential fetal harm.
Rate this question

Topics

Gynecologic Infections

More questions from this topic